Pancreatic Cancer Research

ResearcherColumbia University Irving Medical CenterActive in the last 2 years

Jason Cham

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4748-3930; OpenAlex author ID A5089694286. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Impact of β-Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study. Co-author DOI 10.1158/1055-9965.epi-26-0062↗
  2. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival? First author DOI 10.1002/cam4.5751↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susan Elaine Bates · 1 shared paper, 2026 · strength 0.33
  2. Keith Magnus Sigel · 1 shared paper, 2026 · strength 0.33
  3. Ruth Aroon White · 1 shared paper, 2026 · strength 0.33
  4. Jiheum Park · 1 shared paper, 2026 · strength 0.33
  5. Tito Fojo · 1 shared paper, 2026 · strength 0.33
  6. Aren Ebrahimi · 1 shared paper, 2023 · strength 0.20
  7. Darren S. Sigal · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.